JP2014237724A5 - - Google Patents

Download PDF

Info

Publication number
JP2014237724A5
JP2014237724A5 JP2014190906A JP2014190906A JP2014237724A5 JP 2014237724 A5 JP2014237724 A5 JP 2014237724A5 JP 2014190906 A JP2014190906 A JP 2014190906A JP 2014190906 A JP2014190906 A JP 2014190906A JP 2014237724 A5 JP2014237724 A5 JP 2014237724A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014190906A
Other versions
JP6050295B2 (ja
JP2014237724A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014237724A publication Critical patent/JP2014237724A/ja
Publication of JP2014237724A5 publication Critical patent/JP2014237724A5/ja
Application granted granted Critical
Publication of JP6050295B2 publication Critical patent/JP6050295B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014190906A 2008-09-05 2014-09-19 タンパク質および核酸の連続的指向性進化 Expired - Fee Related JP6050295B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9466608P 2008-09-05 2008-09-05
US61/094,666 2008-09-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011526268A Division JP5723774B2 (ja) 2008-09-05 2009-09-08 タンパク質および核酸の連続的指向性進化

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016037495A Division JP2016104033A (ja) 2008-09-05 2016-02-29 タンパク質および核酸の連続的指向性進化

Publications (3)

Publication Number Publication Date
JP2014237724A JP2014237724A (ja) 2014-12-18
JP2014237724A5 true JP2014237724A5 (ja) 2015-05-21
JP6050295B2 JP6050295B2 (ja) 2016-12-21

Family

ID=41797915

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011526268A Active JP5723774B2 (ja) 2008-09-05 2009-09-08 タンパク質および核酸の連続的指向性進化
JP2014190906A Expired - Fee Related JP6050295B2 (ja) 2008-09-05 2014-09-19 タンパク質および核酸の連続的指向性進化
JP2016037495A Pending JP2016104033A (ja) 2008-09-05 2016-02-29 タンパク質および核酸の連続的指向性進化

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011526268A Active JP5723774B2 (ja) 2008-09-05 2009-09-08 タンパク質および核酸の連続的指向性進化

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016037495A Pending JP2016104033A (ja) 2008-09-05 2016-02-29 タンパク質および核酸の連続的指向性進化

Country Status (5)

Country Link
US (2) US9023594B2 (ja)
EP (2) EP2342336B1 (ja)
JP (3) JP5723774B2 (ja)
CA (3) CA3059768A1 (ja)
WO (1) WO2010028347A2 (ja)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010028347A2 (en) 2008-09-05 2010-03-11 President & Fellows Of Harvard College Continuous directed evolution of proteins and nucleic acids
CA2825370A1 (en) 2010-12-22 2012-06-28 President And Fellows Of Harvard College Continuous directed evolution
US10323236B2 (en) 2011-07-22 2019-06-18 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
DE19216461T1 (de) 2011-10-03 2021-10-07 Modernatx, Inc. Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
WO2014093924A1 (en) 2012-12-13 2014-06-19 Moderna Therapeutics, Inc. Modified nucleic acid molecules and uses thereof
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
US20150165054A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting caspase-9 point mutations
WO2015134121A2 (en) * 2014-01-20 2015-09-11 President And Fellows Of Harvard College Negative selection and stringency modulation in continuous evolution systems
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
WO2016077052A2 (en) 2014-10-22 2016-05-19 President And Fellows Of Harvard College Evolution of proteases
WO2016077125A1 (en) 2014-11-10 2016-05-19 Moderna Therapeutics, Inc. Alternative nucleic acid molecules containing reduced uracil content and uses thereof
WO2016168631A1 (en) * 2015-04-17 2016-10-20 President And Fellows Of Harvard College Vector-based mutagenesis system
WO2017015545A1 (en) 2015-07-22 2017-01-26 President And Fellows Of Harvard College Evolution of site-specific recombinases
US11524983B2 (en) 2015-07-23 2022-12-13 President And Fellows Of Harvard College Evolution of Bt toxins
WO2017019895A1 (en) 2015-07-30 2017-02-02 President And Fellows Of Harvard College Evolution of talens
EP3350333B2 (en) 2015-09-17 2025-08-06 ModernaTX, Inc. Polynucleotides containing a stabilizing tail region
IL310721B2 (en) 2015-10-23 2025-11-01 Harvard College Nucleobase editors and uses thereof
CN110214183A (zh) 2016-08-03 2019-09-06 哈佛大学的校长及成员们 腺苷核碱基编辑器及其用途
WO2018031683A1 (en) 2016-08-09 2018-02-15 President And Fellows Of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
KR102622411B1 (ko) 2016-10-14 2024-01-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
WO2018119042A1 (en) 2016-12-20 2018-06-28 Reintjes Peter B Directed evolution through mutation rate modulation
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
US12390514B2 (en) 2017-03-09 2025-08-19 President And Fellows Of Harvard College Cancer vaccine
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
US11542496B2 (en) 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
KR20240116572A (ko) 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
US11447809B2 (en) 2017-07-06 2022-09-20 President And Fellows Of Harvard College Evolution of tRNA synthetases
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
US12060553B2 (en) 2017-08-25 2024-08-13 President And Fellows Of Harvard College Evolution of BoNT peptidases
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
WO2019056002A1 (en) 2017-09-18 2019-03-21 President And Fellows Of Harvard College CONTINUOUS EVOLUTION FOR STABILIZED PROTEINS
KR20250107288A (ko) 2017-10-16 2025-07-11 더 브로드 인스티튜트, 인코퍼레이티드 아데노신 염기 편집제의 용도
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
WO2019241649A1 (en) 2018-06-14 2019-12-19 President And Fellows Of Harvard College Evolution of cytidine deaminases
US12522807B2 (en) 2018-07-09 2026-01-13 The Broad Institute, Inc. RNA programmable epigenetic RNA modifiers and uses thereof
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US20220282275A1 (en) 2018-11-15 2022-09-08 The Broad Institute, Inc. G-to-t base editors and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
WO2020181195A1 (en) 2019-03-06 2020-09-10 The Broad Institute, Inc. T:a to a:t base editing through adenine excision
WO2020181180A1 (en) 2019-03-06 2020-09-10 The Broad Institute, Inc. A:t to c:g base editors and uses thereof
WO2020181178A1 (en) 2019-03-06 2020-09-10 The Broad Institute, Inc. T:a to a:t base editing through thymine alkylation
WO2020181202A1 (en) 2019-03-06 2020-09-10 The Broad Institute, Inc. A:t to t:a base editing through adenine deamination and oxidation
WO2020181193A1 (en) 2019-03-06 2020-09-10 The Broad Institute, Inc. T:a to a:t base editing through adenosine methylation
WO2020191233A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
US20220204975A1 (en) 2019-04-12 2022-06-30 President And Fellows Of Harvard College System for genome editing
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
JP7759311B2 (ja) 2019-07-19 2025-10-23 フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー リコンビナーゼ組成物及び使用方法
EP4010474A1 (en) 2019-08-08 2022-06-15 The Broad Institute, Inc. Base editors with diversified targeting scope
WO2021030666A1 (en) 2019-08-15 2021-02-18 The Broad Institute, Inc. Base editing by transglycosylation
WO2021067831A1 (en) * 2019-10-03 2021-04-08 North Carolina State University Autonomous inducible directed evolution of complex pathways
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
US20230086199A1 (en) 2019-11-26 2023-03-23 The Broad Institute, Inc. Systems and methods for evaluating cas9-independent off-target editing of nucleic acids
US20250011748A1 (en) 2020-01-28 2025-01-09 The Broad Institute, Inc. Base editors, compositions, and methods for modifying the mitochondrial genome
US20230123669A1 (en) 2020-02-05 2023-04-20 The Broad Institute, Inc. Base editor predictive algorithm and method of use
EP4100519A2 (en) 2020-02-05 2022-12-14 The Broad Institute, Inc. Adenine base editors and uses thereof
EP4100032B1 (en) 2020-02-05 2025-10-15 The Broad Institute, Inc. Gene editing methods for treating spinal muscular atrophy
EP4118206A1 (en) 2020-03-11 2023-01-18 The Broad Institute Inc. Stat3-targeted base editor therapeutics for the treatment of melanoma and other cancers
WO2021202651A1 (en) 2020-04-01 2021-10-07 Voyager Therapeutics, Inc. Redirection of tropism of aav capsids
EP4143315A1 (en) 2020-04-28 2023-03-08 The Broad Institute Inc. <smallcaps/>? ? ?ush2a? ? ? ? ?targeted base editing of thegene
IL297761A (en) 2020-05-08 2022-12-01 Broad Inst Inc Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
CA3193099A1 (en) 2020-09-24 2022-03-31 David R. Liu Prime editing guide rnas, compositions thereof, and methods of using the same
WO2022133266A1 (en) 2020-12-18 2022-06-23 The Broad Institute, Inc. Evolution of botulinum neurotoxin proteases
KR20240011120A (ko) 2020-12-22 2024-01-25 크로마 메디슨, 인크. 후성유전학적 편집을 위한 조성물 및 방법
EP4274894A2 (en) 2021-01-11 2023-11-15 The Broad Institute, Inc. Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
CN115029363B (zh) * 2021-03-05 2023-10-03 江南大学 一种体内连续定向进化系统及其应用
EP4377455A1 (en) 2021-07-28 2024-06-05 The Broad Institute Inc. Methods of periplasmic phage-assisted continuous evolution
JP2024530487A (ja) 2021-08-06 2024-08-21 ザ ブロード インスティテュート，インコーポレーテッド 改善されたプライムエディターおよび使用方法
WO2023076898A1 (en) 2021-10-25 2023-05-04 The Broad Institute, Inc. Methods and compositions for editing a genome with prime editing and a recombinase
WO2023081805A1 (en) 2021-11-05 2023-05-11 The Broad Institute, Inc. Procaspase-cleaving proteases and uses thereof
WO2023196802A1 (en) 2022-04-04 2023-10-12 The Broad Institute, Inc. Cas9 variants having non-canonical pam specificities and uses thereof
JP2025515503A (ja) 2022-04-28 2025-05-15 ザ ブロード インスティテュート，インコーポレーテッド 塩基エディタをコードするａａｖベクターおよびその使用
EP4536688A2 (en) 2022-06-13 2025-04-16 The Broad Institute Inc. Evolved protein degrons
WO2023250148A1 (en) 2022-06-23 2023-12-28 Chroma Medicine, Inc. Compositions and methods for epigenetic editing
JP2025525569A (ja) 2022-07-18 2025-08-05 レナゲード セラピューティクス マネージメント インコーポレイテッド 遺伝子編集成分、システム、及び使用方法
WO2024040083A1 (en) 2022-08-16 2024-02-22 The Broad Institute, Inc. Evolved cytosine deaminases and methods of editing dna using same
WO2024050007A1 (en) 2022-08-31 2024-03-07 The Broad Institute, Inc. Gtp cyclohydrolase-cleaving proteases
WO2024077247A1 (en) 2022-10-07 2024-04-11 The Broad Institute, Inc. Base editing methods and compositions for treating triplet repeat disorders
WO2024074709A1 (en) 2022-10-07 2024-04-11 Universitat Pompeu Fabra Methods and compositions for synthetic evolution
WO2024097874A1 (en) 2022-11-03 2024-05-10 Modernatx, Inc. Chemical stability of mrna
EP4619515A1 (en) 2022-11-17 2025-09-24 The Broad Institute, Inc. Prime editor delivery by aav
WO2024163862A2 (en) 2023-02-03 2024-08-08 The Broad Institute, Inc. Gene editing methods, systems, and compositions for treating spinal muscular atrophy
AU2024270764A1 (en) 2023-05-15 2025-12-04 Nchroma Bio, Inc. Compositions and methods for epigenetic regulation of hbv gene expression
WO2024243415A1 (en) 2023-05-23 2024-11-28 The Broad Institute, Inc. Evolved and engineered prime editors with improved editing efficiency
CN121693564A (zh) 2023-06-26 2026-03-17 夏威夷大学 进化的整合酶和其用于基因组编辑的方法
WO2025054383A1 (en) 2023-09-06 2025-03-13 Modernatx, Inc. Chemical stability of mrna
WO2025155753A2 (en) 2024-01-17 2025-07-24 Renagade Therapeutics Management Inc. Improved gene editing system, guides, and methods
WO2025194124A1 (en) 2024-03-14 2025-09-18 Tessera Therapeutics, Inc. Modified st1cas9 guide nucleic acids
WO2025235876A2 (en) 2024-05-10 2025-11-13 The Broad Institute, Inc. Gasdermin d-cleaving proteases and uses thereof

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0436597B1 (en) 1988-09-02 1997-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
US5637459A (en) 1990-06-11 1997-06-10 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chimeric selex
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK0585287T3 (da) 1990-07-10 2000-04-17 Cambridge Antibody Tech Fremgangsmåde til fremstilling af specifikke bindingsparelementer
CA2095633C (en) * 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
EP1820858B1 (en) 1991-03-01 2009-08-12 Dyax Corporation Chimeric protein comprising micro-protein having two or more disulfide bonds and embodiments thereof
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US5965124A (en) 1991-12-06 1999-10-12 Whitehead Institute For Biomedical Research Replication-competent recombinant viral vaccines and method of producing same
SE9304060D0 (sv) * 1993-12-06 1993-12-06 Bioinvent Int Ab Sätt att selektera specifika bakteriofager
US6887707B2 (en) * 1996-10-28 2005-05-03 University Of Washington Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
GB9701425D0 (en) 1997-01-24 1997-03-12 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
US6156509A (en) * 1997-11-12 2000-12-05 Genencor International, Inc. Method of increasing efficiency of directed evolution of a gene using phagemid
US6884870B2 (en) 1998-03-20 2005-04-26 California Institute Of Technology Fusion proteins for identifying proteases, protease target sites and regulators of protease activity in living cells
WO2000022115A2 (en) 1998-10-13 2000-04-20 Board Of Regents, The University Of Texas System Assays for identifying functional alterations in the p53 tumor suppressor
US6969731B1 (en) 1999-02-19 2005-11-29 The University of Illinois, Board of Trustees Protease inhibitors that overcome drug resistance
US6365410B1 (en) 1999-05-19 2002-04-02 Genencor International, Inc. Directed evolution of microorganisms
US6472147B1 (en) 1999-05-25 2002-10-29 The Scripps Research Institute Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries
ES2327382T3 (es) 1999-07-20 2009-10-29 Morphosys Ag Metodos para presentar (poli)peptidos/proteinas en particulas de bacteriofagos a traves de enlaces disulfuro.
ES2355493T3 (es) 2000-02-18 2011-03-28 The Board Of Trustees Of The Leland Stanford Junior University Recombinasas alteradas para la modificación del genoma.
US6573092B1 (en) * 2000-10-10 2003-06-03 Genvec, Inc. Method of preparing a eukaryotic viral vector
AU2003229998A1 (en) 2002-05-10 2003-11-11 Medical Research Council Activation induced deaminase (aid)
CA2498653C (en) 2002-10-29 2010-12-14 Boehringer Ingelheim International Gmbh Inhibitor-resistant hcv ns3 protease
EP1751180A4 (en) 2004-02-26 2012-01-04 Israel State ENZYMES, CELLS, AND METHODS FOR LOCALLY-SPECIFIC RECOMBINATION AT ASYMMETRIC LOCATIONS
JP3939733B2 (ja) * 2005-08-22 2007-07-04 財団法人かずさディー・エヌ・エー研究所 新規なアポトーシス誘導因子及びそれを利用するアポトーシスの誘導方法
KR100784478B1 (ko) * 2005-12-05 2007-12-11 한국과학기술원 기능요소의 동시 삽입에 의한 신기능을 갖는 단백질을제조하는 방법
WO2008005529A2 (en) * 2006-07-07 2008-01-10 The Trustees Columbia University In The City Of New York Cell-mediated directed evolution
US20110263487A1 (en) 2007-12-20 2011-10-27 University Of Georgia Research Foundation, Inc. Plant Production and Delivery System for Recombinant Proteins as Protein-Flour or Protein-Oil Compositions
WO2009082488A2 (en) 2007-12-24 2009-07-02 Bergenbio As Methods for creating and identifying functional rna interference elements
US20090227463A1 (en) 2008-03-04 2009-09-10 Reif John H Autonomous in vitro evolution
WO2010028347A2 (en) 2008-09-05 2010-03-11 President & Fellows Of Harvard College Continuous directed evolution of proteins and nucleic acids
EP2576798B1 (en) 2010-05-27 2016-04-27 Heinrich-Pette-Institut Leibniz-Institut für experimentelle Virologie-Stiftung bürgerlichen Rechts - Tailored recombinase for recombining asymmetric target sites in a plurality of retrovirus strains
CA2825370A1 (en) 2010-12-22 2012-06-28 President And Fellows Of Harvard College Continuous directed evolution
CA3111953C (en) 2011-04-05 2023-10-24 Cellectis Method for the generation of compact tale-nucleases and uses thereof
US20140201858A1 (en) 2011-05-17 2014-07-17 Transposagen Biopharmaceuticals, Inc Methods for site-specific genetic modification in stem cells using xanthomonas tal nucleases (xtn) for the creation of model organisms
US9341589B2 (en) 2012-06-20 2016-05-17 Board Of Regents, The University Of Texas System Active-electrode integrated biosensor array and methods for use thereof
KR102357105B1 (ko) 2012-09-04 2022-02-08 더 스크립스 리서치 인스티튜트 표적화된 바인딩 특이도를 갖는 키메라 폴리펩타이드들
EP2970923B1 (en) 2013-03-13 2018-04-11 President and Fellows of Harvard College Mutants of cre recombinase
WO2014157820A1 (ko) 2013-03-26 2014-10-02 서울대학교산학협력단 나비목 해충에 대한 살충 활성이 향상된 신규의 바실러스 투린지엔시스 내독소단백질 유전자 및 그 제조방법
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
WO2015134121A2 (en) 2014-01-20 2015-09-11 President And Fellows Of Harvard College Negative selection and stringency modulation in continuous evolution systems
US11524983B2 (en) 2015-07-23 2022-12-13 President And Fellows Of Harvard College Evolution of Bt toxins

Similar Documents

Publication Publication Date Title
BR112016018895A2 (ja)
BR112016016900A2 (ja)
BR112016017696A2 (ja)
JP2014237724A5 (ja)
BR112016017131A2 (ja)
BR112016015605A2 (ja)
BR112016016546A2 (ja)
BR112016018278A2 (ja)
BR112016016741A2 (ja)
BR112016017226A2 (ja)
BR112016013819A2 (ja)
BR112016018800A2 (ja)
BR112016017713A2 (ja)
BR112016012729A2 (ja)
BR112016017660A2 (ja)
BR112016017469A2 (ja)
BR112016018632A2 (ja)
BR112016017502A2 (ja)
BR112016018401A2 (ja)
BR112016017093A2 (ja)
BR112016014619A2 (ja)
AP2017009684A0 (ja)
BR112016018896A2 (ja)
BR112016016575A2 (ja)
BR112016017421A2 (ja)